Advertisement
Screener

TALPHERA, INC. (TLPH) Increase (Decrease) in Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

TALPHERA, INC. Increase (Decrease) in Deferred Revenue

TALPHERA, INC. (TLPH) reported Increase (Decrease) in Deferred Revenue of -$272.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-05.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-05

  • TALPHERA, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$90.00K.
  • TALPHERA, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$91.00K.
  • TALPHERA, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$91.00K.
  • TALPHERA, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$90.00K.
  • TALPHERA, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$361.00K, a 136.50% decline from fiscal 2016.
  • TALPHERA, INC. increase (decrease) in deferred revenue for fiscal 2016 was $989.00K, a 26.15% increase from fiscal 2015.
  • TALPHERA, INC. increase (decrease) in deferred revenue for fiscal 2015 was $784.00K.
  • TALPHERA, INC. increase (decrease) in deferred revenue for fiscal 2014 was -$217.00K, a 108.25% decline from fiscal 2013.
Period endIncrease (Decrease) in Deferred Revenue 3 monthIncrease (Decrease) in Deferred Revenue 6 monthIncrease (Decrease) in Deferred Revenue 9 monthIncrease (Decrease) in Deferred Revenue 12 month
2018-09-30-$90.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
-$181.00K
derived: sum of 2 quarters · filed 2018-11-05
-$272.00K
10-Q · filed 2018-11-05
-$362.00K
derived: sum of 4 quarters · filed 2018-11-05
2018-06-30-$91.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$182.00K
10-Q · filed 2018-08-02
-$272.00K
derived: sum of 3 quarters · filed 2018-08-02
-$362.00K
derived: sum of 4 quarters · filed 2018-11-05
2018-03-31-$91.00K
10-Q · filed 2018-05-10
-$181.00K
derived: sum of 2 quarters · filed 2018-05-10
-$271.00K
derived: sum of 3 quarters · filed 2018-11-05
-$362.00K
derived: sum of 4 quarters · filed 2018-11-05
2017-12-31-$90.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
-$180.00K
derived: sum of 2 quarters · filed 2018-11-05
-$271.00K
derived: sum of 3 quarters · filed 2018-11-05
-$361.00K
10-K · filed 2018-03-09
2017-09-30-$90.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
-$181.00K
derived: sum of 2 quarters · filed 2018-11-05
-$271.00K
10-Q · filed 2018-11-05
-$362.00K
derived: sum of 4 quarters · filed 2018-11-05
2017-06-30-$91.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$181.00K
10-Q · filed 2018-08-02
-$272.00K
derived: sum of 3 quarters · filed 2018-08-02
-$65.00K
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31-$90.00K
10-Q · filed 2018-05-10
-$181.00K
derived: sum of 2 quarters · filed 2018-05-10
$26.00K
derived: sum of 3 quarters · filed 2018-05-10
$296.00K
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31-$91.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$116.00K
derived: sum of 2 quarters · filed 2018-03-09
$386.00K
derived: sum of 3 quarters · filed 2018-03-09
$989.00K
10-K · filed 2018-03-09
2016-09-30$207.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$477.00K
derived: sum of 2 quarters · filed 2017-11-09
$1.08M
10-Q · filed 2017-11-09
$1.07M
derived: sum of 4 quarters · filed 2018-03-09
2016-06-30$270.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$873.00K
10-Q · filed 2017-08-02
$865.00K
derived: sum of 3 quarters · filed 2018-03-09
$2.32M
derived: sum of 4 quarters · filed 2018-03-09
2016-03-31$603.00K
10-Q · filed 2017-05-08
$595.00K
derived: sum of 2 quarters · filed 2018-03-09
$2.05M
derived: sum of 3 quarters · filed 2018-03-09
$1.57M
derived: sum of 4 quarters · filed 2018-03-09
2015-12-31-$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$1.45M
derived: sum of 2 quarters · filed 2018-03-09
$965.00K
derived: sum of 3 quarters · filed 2018-03-09
$784.00K
10-K · filed 2018-03-09
2015-09-30$1.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$973.00K
derived: sum of 2 quarters · filed 2016-11-02
$792.00K
10-Q · filed 2016-11-02
$566.00K
derived: sum of 4 quarters · filed 2017-03-03
2015-06-30-$486.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29
-$667.00K
10-Q · filed 2016-07-29
-$893.00K
derived: sum of 3 quarters · filed 2017-03-03
-$717.00K
derived: sum of 4 quarters · filed 2017-03-03
2015-03-31-$181.00K
10-Q · filed 2016-05-02
-$407.00K
derived: sum of 2 quarters · filed 2017-03-03
-$231.00K
derived: sum of 3 quarters · filed 2017-03-03
-$303.00K
derived: sum of 4 quarters · filed 2017-03-03
2014-12-31-$226.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03
-$50.00K
derived: sum of 2 quarters · filed 2017-03-03
-$122.00K
derived: sum of 3 quarters · filed 2017-03-03
-$217.00K
10-K · filed 2017-03-03
2014-09-30$176.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03
$104.00K
derived: sum of 2 quarters · filed 2015-11-03
$9.00K
10-Q · filed 2015-11-03
2014-06-30-$72.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04
-$167.00K
10-Q · filed 2015-08-04
2014-03-31-$95.00K
10-Q · filed 2015-05-05
2013-12-31$2.63M
10-K · filed 2016-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
HYPERION DEFI, INC. (HYPD)United States$0.065B
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99